Launching Status COVID-19/Flu 15 Minute Visual Read Rapid Test in the USA


Launching DPP® SARS-CoV-2 Antigen System in Brazil


Introducing DPP HIV-Syphilis: The First & Only FDA Approved HIV-Syphilis Rapid Test


Launching the First Rapid Zika IgM Test with FDA 510(k) Clearance


Stay up to date with our latest news.


Watch the recorded Webinar, Fighting the Syphilis & HIV Epidemics: Voices from the Field

Date: May 27th, 2021Time: 2:30pm-3:45pm ESTHost: National Coalition of STD Directors   Description The National…
Status COVID-19 Flu Background Image, Nurse and Patients

Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu

Apr 1, 2021: In-licensed Rapid Point-of-Care Test Available for Use in Detecting COVID-19 Antigens, Flu…
David W. Bespalko

Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors

Mar 8, 2021 HAUPPAUGE, N.Y., (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company…
About Us

We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care.

Our mission is to be a leader in the development, manufacturing and commercialization of diagnostic solutions. We are dedicated to delivering exceptional point-of-care products that are easy to use, fast and accurate.

Our Core Values: “RAPID”






Learn More
Investor Relations

Chembio is a leading point of care diagnostics company focused on detecting and diagnosing infectious diseases.

Our patented DPP® technology platform uses a small drop of blood from the fingertip and provides high-quality, cost-effective results in 15-20 minutes. Our products are sold globally, directly and through distributors, to hospitals, clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

Learn More
Chembio Testing

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.